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Introduction
The in vitro anti-Helicobacter pylori (HP) effect of many herbs contained in Kampo medicines has been reported ; however, whether such herbs have an actual anti-HP effect on patients or not is unknown. We examined the relationship between the existence of HP and Kampo medicines used in patients.
Patients and Methods
In Toyama Medical and Pharmaceutical University Hospital, we investigated HP infection in patients who were continuously administered Kampo medicines. Those who had previously received eradication therapy for HP were excluded. The enrolled patients had taken Kampo medicines until the day before upper GI endoscopy. During upper GI endoscopy, two specimens were obtained from the greater cavature of the antrum and upper body of the stomach, and then were processed for rapid urease test, the CLO-test (Campylobacter-Like Organism test, Delta West, Bentley, Australia). Each Kampo medicine administered to CLO-positive patients and CLO-negative patients was examined.
Results
The clinical backgrounds of 34 consecutively enrolled patients are shown in Table 1 . CLO was positive in 18 patients (52.9%). Mean age of HPpositive patients did not differ from that of HPnegative patients. Patients in both groups had taken various Kampo medicines for more than one month, and every Kampo medicine except one in both groups contained herbs that had been reported to have an in vitro anti-HP effect.
Discussion
The in vitro anti-HP effects of coptis rhizome (oren), phellodendron bark (obaku), forsythia fruit (rengyo),1 scutellaria root (ogon), gardenia fruit (sanshishi),2 rhubarb (daio), roast glycyrrhiza root 
